patent/SV-2006002473-A

Predicate	Object
assignee	http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1f6a5d00d580b88a56cd983a1803f966
classificationCPCInventive	http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D491-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-407
classificationIPCInventive	http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D491-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D313-00
filingDate	2006-04-06-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor	http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5beaaaacb6dff6e8bcd4fd6974ee7c74
publicationDate	2009-11-24-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber	SV-2006002473-A
titleOfInvention	ORTORROMBICAL CRYSTAL FORM OF ASENAPINE MALEATE AND ITS USE IN THE TREATMENT OF MENTAL DISORDERS REF. 2005,893 (806,671)
abstract	THE INVENTION REFERS TO AN ORTORROMBICAL CRYSTAL FORM OF COMPOUND (Z) -2-TRANS-5-CHLORINE-2,3, 3A, 12B-TETRAHYDRO-2-METHYL-1H-DIBENZ [2,3: 6,7 ] OXEPINO [4,5-C] PIRROL, TO METHODS FOR THE PREPARATION OF THIS CRYSTAL FORM AND TO PHARMACEUTICAL COMPOSITIONS THAT INCLUDE AN ORTHROMBIC CRYSTAL FORM
priorityDate	2005-04-07-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type	http://data.epo.org/linked-data/def/patent/Publication

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6917875 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8027 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID449104644 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID410031093

Total number of triples: 19.